Buscapina Tablet, Coated
Product Images NDC 69729-818

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Buscapina (NDC 69729-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opmx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch (Recd. From Client Buscapina Caplet On Cc 05 03 2026 001)

This is a description of Buscapina®, a medication that contains acetaminophen, caffeine, and pyrilamine maleate to relieve symptoms associated with menstrual periods such as cramps, bloating, headache, backache, and fatigue. The product comes in caplet form, with a recommended dosage of 2 caplets every 6 hours for adults and children over 12 years old, not exceeding 6 caplets per day. It includes warnings about liver damage from acetaminophen and allergic reactions. The medication should be stored between 59-86°F and the outer package should be kept for complete product information.*

FDA Label Image

Pdp (F879c3057e3f08aa8e5e5b0f946334cbd98863dbbecfdb80ad33e00a4608 001)

This is a drug fact sheet which provides information on the active ingredients, purpose, uses, and warnings of a medication for relieving symptoms such as pain, headache, backache, bloating, fatigue, and cramps. It contains details on dosage for adults and children, as well as inactive ingredients and contact information for questions or comments. The product is a combination of acetaminophen and pyrilamine maleate and is intended for temporary relief of various symptoms. The text also includes instructions in Spanish and details about potential side effects and precautions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.